Clinical Trials Directory

Trials / Completed

CompletedNCT00622037

Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Bp Consulting, Inc · Network
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To evaluate and compare the effects of PEG-400 based artificial tear and Systane tears in mild-moderate dry eye patients. TBUT, Visual impact and subjective evaluations will be assessed in this month long trial.

Conditions

Interventions

TypeNameDescription
DRUGPEG-400 based artificial tearInstill one drop in the randomized eye four times daily. Can be used more frequently if needed
DRUGSystaneInstill one drop in the randomized eye four times daily. Can be used more frequently if needed

Timeline

Start date
2008-02-01
Primary completion
2008-05-01
Completion
2008-05-01
First posted
2008-02-22
Last updated
2010-02-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00622037. Inclusion in this directory is not an endorsement.